Relapsing Multiple Sclerosis

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

This is the original ClinicalTrials.gov condition label, found in 86 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.